Raphael Pharmaceutical Inc. (RAPH)
OTCMKTS
· Delayed Price · Currency is USD
1.400
0.00 (0.00%)
At close: Jan 20, 2026
Raphael Pharmaceutical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 0 | 0.02 | 0.23 | 0.29 | 0.15 | 0.1 | Upgrade
|
| Cash & Short-Term Investments | 0 | 0.02 | 0.23 | 0.29 | 0.15 | 0.1 | Upgrade
|
| Cash Growth | -92.50% | -91.74% | -20.14% | 88.23% | 61.05% | 90.00% | Upgrade
|
| Other Receivables | - | 0 | 0.01 | 0.04 | 0.09 | 0.03 | Upgrade
|
| Receivables | - | 0 | 0.01 | 0.04 | 0.09 | 0.03 | Upgrade
|
| Prepaid Expenses | - | 0 | - | 0.01 | 0.18 | 0.2 | Upgrade
|
| Total Current Assets | 0.01 | 0.03 | 0.24 | 0.33 | 0.42 | 0.32 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | - | - | Upgrade
|
| Total Assets | 0.01 | 0.03 | 0.24 | 0.33 | 0.42 | 0.32 | Upgrade
|
| Accounts Payable | 0.48 | 0.13 | 0.07 | 0.07 | 0.11 | - | Upgrade
|
| Accrued Expenses | 0.76 | 0.6 | 0.06 | 0.16 | 0.19 | 0.01 | Upgrade
|
| Short-Term Debt | 0.04 | 0.04 | - | - | - | 0.36 | Upgrade
|
| Total Current Liabilities | 1.27 | 0.77 | 0.13 | 0.23 | 0.29 | 0.37 | Upgrade
|
| Total Liabilities | 1.27 | 0.77 | 0.13 | 0.23 | 0.29 | 0.37 | Upgrade
|
| Common Stock | 0.2 | 0.19 | 0.19 | 0.16 | 0.13 | 0.1 | Upgrade
|
| Additional Paid-In Capital | 8.44 | 7.96 | 7.39 | 5.98 | 2.67 | 0.91 | Upgrade
|
| Retained Earnings | -9.9 | -8.89 | -7.37 | -6.03 | -2.67 | -1.04 | Upgrade
|
| Comprehensive Income & Other | - | - | -0.1 | - | - | - | Upgrade
|
| Shareholders' Equity | -1.26 | -0.74 | 0.11 | 0.11 | 0.13 | -0.04 | Upgrade
|
| Total Liabilities & Equity | 0.01 | 0.03 | 0.24 | 0.33 | 0.42 | 0.32 | Upgrade
|
| Total Debt | 0.04 | 0.04 | - | - | - | 0.36 | Upgrade
|
| Net Cash (Debt) | -0.04 | -0.02 | 0.23 | 0.29 | 0.15 | -0.26 | Upgrade
|
| Net Cash Growth | - | - | -20.14% | 88.23% | - | - | Upgrade
|
| Net Cash Per Share | -0.00 | -0.00 | 0.01 | 0.02 | 0.01 | -0.03 | Upgrade
|
| Filing Date Shares Outstanding | 19.63 | 19.63 | 18.66 | 16.14 | 12.97 | 0.1 | Upgrade
|
| Total Common Shares Outstanding | 19.63 | 18.7 | 18.5 | 15.62 | 12.97 | 0.1 | Upgrade
|
| Working Capital | -1.27 | -0.74 | 0.11 | 0.1 | 0.13 | -0.04 | Upgrade
|
| Book Value Per Share | -0.06 | -0.04 | 0.01 | 0.01 | 0.01 | -0.43 | Upgrade
|
| Tangible Book Value | -1.26 | -0.74 | 0.11 | 0.11 | 0.13 | -0.04 | Upgrade
|
| Tangible Book Value Per Share | -0.06 | -0.04 | 0.01 | 0.01 | 0.01 | -0.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.